Viewing Study NCT02828358


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-02-26 @ 2:50 PM
Study NCT ID: NCT02828358
Status: COMPLETED
Last Update Posted: 2025-02-27
First Post: 2016-07-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Leukemia of Ambiguous Lineage View
None B Acute Lymphoblastic Leukemia View
None Mixed Phenotype Acute Leukemia View
Keywords: